During the past decade, Tulane University Health Sciences Center conducted 71 clinical trials. In the 10-year time frame, 71 clinical trials started and 121 clinical trials were completed, i.e. on average, 170.4% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 57 clinical trials were completed. i.e. 228% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tulane University Health Sciences Center" #1 sponsor was "Children's Oncology Group" with 52 trials, followed by "National Cancer Institute (NCI)" with 52 trials sponsored, "SWOG Cancer Research Network" with 20 trials sponsored, "University of North Carolina, Chapel Hill" with 9 trials sponsored and "Gilead Sciences" with 9 trials sponsored. Other sponsors include 108 different institutions and companies that sponsored additional 59 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tulane University Health Sciences Center" #1 collaborator was "National Cancer Institute (NCI)" with 101 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 11 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 11 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 7 trials as a collaborator. Other collaborators include 97 different institutions and companies that were collaborators in the rest 70 trials.

According to Clinical.Site data, the most researched conditions in "Tulane University Health Sciences Center" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Acute Lymphoblastic Leukemia" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Fallopian Tube Transitional Cell Carcinoma" (7 trials) and "Nonalcoholic Steatohepatitis" (7 trials). Many other conditions were trialed in "Tulane University Health Sciences Center" in a lesser frequency.

Most popular intervention types in "Tulane University Health Sciences Center" are "Drug" (192 trials), "Other" (121 trials), "Biological" (69 trials), "Procedure" (44 trials) and "Radiation" (40 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (75 trials), "Quality-of-Life Assessment" (36 trials), "Placebo" (30 trials), "Questionnaire Administration" (28 trials) and "Cyclophosphamide" (27 trials). Other intervention names were less common.

The vast majority of trials in "Tulane University Health Sciences Center" are 213 trials for "All" genders, 27 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are NaN active trials in "Tulane University Health Sciences Center". undefined are not yet recruiting, 27 are recruiting, 73 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 133 completed trials in Tulane University Health Sciences Center, undefined suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Tulane University Health Sciences Center, 7 "Phase 1" clinical trials were conducted, 74 "Phase 2" clinical trials and 132 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 9 trials that are defined as “Not Applicable".